Thus, the finding of elevated ANGPTL3 levels in patients with lipodystrophy and their reduction following leptin treatment is consistent with the results obtained in leptin deficient mice and suggests that ANGPTL3 may contribute to hypertriglyceridemia in leptin deficient states. Here, ANGPTL3 is linked to lipodystrophy.